The global brachytherapy market is projected to reach USD 1,241.5 Million by 2028, growing at a CAGR of 6.8%. Growing prevalence of malignancy, technological progressions in minimally invasive surgical techniques and increasing government initiatives to surge cognizance are some of the factors driving the growth of the global brachytherapy market.

Adroit Market Research report on global brachytherapy market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global brachytherapy market have been studied in detail.

Radiation therapy is one of the powerful treatment modality in treating numerous tumors prominently oral cancers. Cells in oral cancers are elusive to radiation which commands exploration of innumerable modalities of radiation therapy. Brachytherapy is a unique modality which has a demonstrated history of efficacy and future that needs exploration.

The global brachytherapy market is categorized based on application and type. On the basis of application, the market is segmented into gynecologic, prostate, breast, and other types of cancer. The prostate cancer segment dominated the market in 2020, while the breast cancer brachytherapy application segment is expected to witness a highest CAGR during the forecast period.

North America dominated the market for brachytherapy in 2020, while Asia Pacific is set to grow at a highest CAGR due to growing awareness about innovative treatment options. Key players of the global brachytherapy market include Boston Scientific, iCAD, Cianna Medical, C.R. Bard, Cook Medical, GE Healthcare, Elekta, Huiheng Medical, IsoRay, Olympus among others.

Key segments of the global brachytherapy market

Application Overview, 2018-2028 (USD Million)

• Prostate Cancer         
• Gynaecological Cancer
• Breast Cancer
• Others

Type Overview, 2018-2028 (USD Million)

• High Dose Rate
• Low Dose Rate

Regional Overview, 2018-2028 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • GCC
  • South Africa